BACKGROUND: Natural orifice transluminal endoscopic surgery procedures have evolved over the past few years. A transvaginal approach is a promising alternative for intraperitoneal procedures. Our objective was to evaluate the safety and feasibility of transvaginal organ extraction. METHODS: This institutional review board-approved protocol involved retrospective review of an ongoing prospective study. Female subjects who presented to our hospital for elective cholecystectomy, appendectomy, or sleeve gastrectomy were offered participation in the study. Eligible patients met the following criteria: age between 18 and 75, diagnosis of gallbladder disease, acute appendicitis, or morbid obesity who desired surgical treatment. A hybrid transvaginal natural orifice approach was used in this series. RESULTS: Thirty-four women underwent transvaginal organ extraction between September 2007 and January 2012. The mean age was 40 ± 12.1 years (range 23-63 years). The mean body mass index was 27 ± 6.4 kg/m(2) (range 16-43 kg/m(2)). All patients had an American Society of Anesthesiologists classification of two or below. The mean operative time for cholecystectomy, appendectomy, and sleeve gastrectomy was 90, 71, and 135 min, respectively. There were no conversions to open operation and no intraoperative complications. The mean hospital stay was 2 days for all cases. Patients were followed for a mean of 24 months (range 1-61 months). There were two pregnancies and two successful vaginal deliveries. Six patients (18 %) had minor complaints of spotting or heavy menses in the immediate postoperative period that resolved with conservative measures. There were no abdominal wall complications. There were no long-term complications and no mortalities. CONCLUSIONS: This initial experience suggests that this surgical approach is safe, does not increase length of stay, and has no long-term vaginal complications. Given this attractive profile, a transvaginal approach may prove to be a superior mode of organ extraction, although randomized studies and long-term follow-up are needed.
BACKGROUND: Natural orifice transluminal endoscopic surgery procedures have evolved over the past few years. A transvaginal approach is a promising alternative for intraperitoneal procedures. Our objective was to evaluate the safety and feasibility of transvaginal organ extraction. METHODS: This institutional review board-approved protocol involved retrospective review of an ongoing prospective study. Female subjects who presented to our hospital for elective cholecystectomy, appendectomy, or sleeve gastrectomy were offered participation in the study. Eligible patients met the following criteria: age between 18 and 75, diagnosis of gallbladder disease, acute appendicitis, or morbid obesity who desired surgical treatment. A hybrid transvaginal natural orifice approach was used in this series. RESULTS: Thirty-four women underwent transvaginal organ extraction between September 2007 and January 2012. The mean age was 40 ± 12.1 years (range 23-63 years). The mean body mass index was 27 ± 6.4 kg/m(2) (range 16-43 kg/m(2)). All patients had an American Society of Anesthesiologists classification of two or below. The mean operative time for cholecystectomy, appendectomy, and sleeve gastrectomy was 90, 71, and 135 min, respectively. There were no conversions to open operation and no intraoperative complications. The mean hospital stay was 2 days for all cases. Patients were followed for a mean of 24 months (range 1-61 months). There were two pregnancies and two successful vaginal deliveries. Six patients (18 %) had minor complaints of spotting or heavy menses in the immediate postoperative period that resolved with conservative measures. There were no abdominal wall complications. There were no long-term complications and no mortalities. CONCLUSIONS: This initial experience suggests that this surgical approach is safe, does not increase length of stay, and has no long-term vaginal complications. Given this attractive profile, a transvaginal approach may prove to be a superior mode of organ extraction, although randomized studies and long-term follow-up are needed.
Authors: Riccardo Autorino; Rachid Yakoubi; Wesley M White; Matthew Gettman; Marco De Sio; Carmelo Quattrone; Carmine Di Palma; Alessandro Izzo; Jeorge Correia-Pinto; Jihad H Kaouk; Estevão Lima Journal: BJU Int Date: 2013-01 Impact factor: 5.588
Authors: Ricardo A Torres; Raúl D Orban; Laura Tocaimaza; Guillermo Vallejos Pereira; José René Arévalo Journal: World J Surg Date: 2012-07 Impact factor: 3.352
Authors: Sheetal Nijhawan; Juan S Barajas-Gamboa; Saniea Majid; Garth R Jacobsen; Michael F Sedrak; Bryan J Sandler; Mark A Talamini; Santiago Horgan Journal: Surg Endosc Date: 2012-07-18 Impact factor: 4.584
Authors: Dirk R Bulian; Linda Trump; Jürgen Knuth; Nicola Cerasani; Markus M Heiss Journal: Langenbecks Arch Surg Date: 2013-03-01 Impact factor: 3.445
Authors: Carrie Y Peterson; Sonia Ramamoorthy; Barbara Andrews; Santiago Horgan; Mark Talamini; Alana Chock Journal: Surg Endosc Date: 2008-12-05 Impact factor: 4.584
Authors: Antonio Brescia; Luigi Masoni; Marcello Gasparrini; Giuseppe Nigri; Umile Michele Cosenza; Anna Dall'Oglio; Alessandra Pancaldi; Francesco Saverio Mari Journal: Surgeon Date: 2012-11-24 Impact factor: 2.392
Authors: Santiago Horgan; Kari Thompson; Mark Talamini; Alberto Ferreres; Garth Jacobsen; Georg Spaun; John Cullen; Lee Swanstrom Journal: Surg Endosc Date: 2010-08-24 Impact factor: 4.584
Authors: Juan S Barajas-Gamboa; Geylor Acosta; Thomas J Savides; Jason K Sicklick; Syed M Abbas Fehmi; Alisa M Coker; Shannon Green; Ryan Broderick; Diego F Nino; Cristina R Harnsberger; Martin A Berducci; Bryan J Sandler; Mark A Talamini; Garth R Jacobsen; Santiago Horgan Journal: Surg Endosc Date: 2014-10-11 Impact factor: 4.584